UNMC faculty, staff and students have the opportunity to know their risk for rheumatoid arthritis (RA) thanks to a research study conducted in part here at the med center.
Investigators in the UNMC Division of Rheumatology are collaborating on ARA08: Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA) (#135-16-FB). Study participants will have their blood tested for the marker anti-ccp -- which can predict eventual onset of the disease.
Researchers want to know if early treatment may prevent or delay RA in high-risk individuals. Individuals identified as high risk -- found to have elevated levels of anti-ccp -- may be eligible to participate in further study, though that is optional. Rheumatoid arthritis (RA) is a disease where the immune system attacks the joints, leading to joint inflammation and damage, disability and many other increased risks.
For information, contact Sherrie Edwards, clinical research coordinator, via email or at 402-559-8140.